At the end of a year which brought a lot of change and uncertainty to the world around us, we would like to reflect on c4c´s achievements of the past year and to look forward to what lies ahead in the coming months.
Patent ductus arteriosus (PDA) in preterm infants is associated with increased morbidities and mortality. Prophylactic treatment with cyclooxygenase inhibitors, as indomethacin or ibuprofen, failed to demonstrate significant clinical benefits. Acetaminophen may represent an alternative treatment option. To read full article, click here Related posts: c4c publication on efficient paediatric formulation development How c4c is improving…
We recently collaborated with FAIRPlus, another IMI funded project, as part of our WP5 data harmonization and standardization tasks to look at ways to make metadata collected about clinical trials more FAIR
The POLPEDNET network was established in 2017 due to initiative of Children’s Memorial Health Institute by representatives of four biggest paediatric hospitals in Poland